4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Traws Pharma, Inc. (TRAW) operates in the Biotechnology industry and is headquartered in Newtown, United States with about 4 employees. Its market capitalization is roughly $10 million. In the fiscal year ended 2025-12-31, TRAW reported $3M in revenue and $9M in net income.
Traws Pharma, Inc., a clinical-stage biopharmaceutical company, develops small synthetic molecules for respiratory viral diseases and cancer.
Interactive charts & full statements → Open the TRAW valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $3M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($18M) | ($25M) | ($20M) | ($20M) | — |
| Net Income | $9M | ($166M) | ($19M) | ($19M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $3M | $0M | — |
| Operating Income (EBIT) | ($7M) | ($7M) | ($4M) | ($1M) | ($5M) | — |
| Net Income | ($7M) | ($7M) | ($4M) | ($1M) | $22M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $11M | $25M | $23M | $39M | — |
| Total Liabilities | $11M | $57M | $12M | $11M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TRAW viewer.
About TickerBase · Data methodology & sources